83/120
3.5 / 5 stars
All 120 Win/Lose results shown below
IDXX Roast Me summary
IDEXX LABORATORIES INC /DE (IDXX). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Win.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseIDXX / S&P -6.31% / 15.20% |
LoseIDXX / S&P 12.77% / 15.00% |
LoseIDXX / S&P 18.48% / 50.40% |
| 2026-Q11/3 |
LoseIDXX / S&P -16.95% / -4.33% |
WinIDXX / S&P 13.08% / 11.30% |
LoseIDXX / S&P 25.60% / 27.70% |
| 2025-Q43/3 |
WinIDXX / S&P 5.89% / 2.65% |
WinIDXX / S&P 10.42% / 9.00% |
WinIDXX / S&P 22.59% / 13.40% |
| 2025-Q33/3 |
WinIDXX / S&P 19.12% / 8.12% |
WinIDXX / S&P 8.39% / 4.61% |
WinIDXX / S&P 21.72% / 13.45% |
| 2025-Q23/3 |
WinIDXX / S&P 27.72% / 10.94% |
WinIDXX / S&P 6.68% / 4.83% |
WinIDXX / S&P 19.03% / 10.63% |
| 2025-Q12/3 |
WinIDXX / S&P 1.57% / -4.27% |
WinIDXX / S&P 5.56% / 4.98% |
LoseIDXX / S&P 4.84% / 10.57% |
| 2024-Q41/3 |
LoseIDXX / S&P -18.17% / 2.41% |
WinIDXX / S&P 6.46% / 5.25% |
LoseIDXX / S&P 6.06% / 6.15% |
| 2024-Q31/3 |
LoseIDXX / S&P 3.70% / 5.89% |
WinIDXX / S&P 7.16% / 5.89% |
LoseIDXX / S&P 5.61% / 6.11% |
| 2024-Q22/3 |
LoseIDXX / S&P -9.77% / 4.28% |
WinIDXX / S&P 7.70% / 5.38% |
WinIDXX / S&P 7.00% / 5.12% |
| 2024-Q12/3 |
LoseIDXX / S&P -2.72% / 10.56% |
WinIDXX / S&P 8.57% / 5.71% |
WinIDXX / S&P 24.04% / 5.59% |
| 2023-Q43/3 |
WinIDXX / S&P 26.94% / 11.69% |
WinIDXX / S&P 8.72% / 6.81% |
WinIDXX / S&P 25.28% / 7.78% |
| 2023-Q31/3 |
LoseIDXX / S&P -12.93% / -3.27% |
LoseIDXX / S&P 7.43% / 7.52% |
WinIDXX / S&P 24.65% / -5.03% |
| 2023-Q21/3 |
LoseIDXX / S&P 0.43% / 8.74% |
LoseIDXX / S&P 6.21% / 9.50% |
WinIDXX / S&P 21.68% / -8.57% |
| 2023-Q12/3 |
WinIDXX / S&P 22.58% / 7.50% |
LoseIDXX / S&P 4.79% / 10.77% |
WinIDXX / S&P -2.46% / -15.69% |
| 2022-Q42/3 |
WinIDXX / S&P 25.22% / 7.56% |
LoseIDXX / S&P 4.73% / 11.88% |
WinIDXX / S&P -6.63% / -17.99% |
| 2022-Q30/3 |
LoseIDXX / S&P -7.11% / -4.88% |
LoseIDXX / S&P 6.53% / 13.47% |
LoseIDXX / S&P -9.85% / -1.41% |
| 2022-Q20/3 |
LoseIDXX / S&P -35.89% / -16.10% |
LoseIDXX / S&P 8.60% / 13.71% |
LoseIDXX / S&P -7.63% / 11.04% |
| 2022-Q10/3 |
LoseIDXX / S&P -16.92% / -4.60% |
LoseIDXX / S&P 14.56% / 15.97% |
LoseIDXX / S&P 9.78% / 42.23% |
| 2021-Q41/3 |
LoseIDXX / S&P 5.88% / 11.03% |
WinIDXX / S&P 18.79% / 15.00% |
LoseIDXX / S&P 28.17% / 96.40% |
| 2021-Q31/3 |
LoseIDXX / S&P -1.53% / 0.58% |
WinIDXX / S&P 21.00% / 10.77% |
LoseIDXX / S&P 52.09% / 69.42% |
| 2021-Q23/3 |
WinIDXX / S&P 29.07% / 8.55% |
WinIDXX / S&P 23.11% / 6.58% |
WinIDXX / S&P 58.60% / 51.81% |
| 2021-Q12/3 |
LoseIDXX / S&P -2.11% / 6.17% |
WinIDXX / S&P 16.31% / -1.06% |
WinIDXX / S&P 55.40% / 7.39% |
| 2020-Q43/3 |
WinIDXX / S&P 27.16% / 12.15% |
WinIDXX / S&P 12.45% / -3.72% |
WinIDXX / S&P 37.22% / -33.42% |
| 2020-Q33/3 |
WinIDXX / S&P 19.07% / 8.93% |
WinIDXX / S&P 10.22% / -2.04% |
WinIDXX / S&P 19.33% / -27.10% |
| 2020-Q23/3 |
WinIDXX / S&P 36.29% / 20.54% |
WinIDXX / S&P 8.02% / -0.46% |
WinIDXX / S&P 14.50% / -27.11% |
| 2020-Q13/3 |
WinIDXX / S&P -7.23% / -19.60% |
WinIDXX / S&P 9.13% / 3.47% |
WinIDXX / S&P 13.12% / -14.75% |
| 2019-Q42/3 |
LoseIDXX / S&P -3.97% / 9.07% |
WinIDXX / S&P 8.75% / 5.36% |
WinIDXX / S&P 14.79% / 2.99% |
| 2019-Q32/3 |
LoseIDXX / S&P -1.23% / 1.70% |
WinIDXX / S&P 8.34% / 5.02% |
WinIDXX / S&P 29.30% / 0.21% |
| 2019-Q23/3 |
WinIDXX / S&P 23.14% / 4.30% |
WinIDXX / S&P 8.24% / 6.64% |
WinIDXX / S&P 33.53% / 8.65% |
| 2019-Q13/3 |
WinIDXX / S&P 20.20% / 13.65% |
WinIDXX / S&P 10.12% / 8.12% |
WinIDXX / S&P 38.99% / 14.29% |
| 2018-Q42/3 |
LoseIDXX / S&P -25.49% / -13.52% |
WinIDXX / S&P 12.40% / 9.05% |
WinIDXX / S&P 44.90% / 18.23% |
| 2018-Q33/3 |
WinIDXX / S&P 14.55% / 7.71% |
WinIDXX / S&P 13.85% / 10.21% |
WinIDXX / S&P 20.78% / 19.06% |
| 2018-Q23/3 |
WinIDXX / S&P 13.87% / 3.43% |
WinIDXX / S&P 13.65% / 9.03% |
WinIDXX / S&P 18.90% / 14.46% |
| 2018-Q13/3 |
WinIDXX / S&P 22.39% / -0.76% |
WinIDXX / S&P 12.35% / 7.68% |
WinIDXX / S&P 17.78% / 12.46% |
| 2017-Q42/3 |
LoseIDXX / S&P 0.57% / 6.64% |
WinIDXX / S&P 10.91% / 7.03% |
WinIDXX / S&P 20.49% / 13.82% |
| 2017-Q32/3 |
LoseIDXX / S&P -3.67% / 4.48% |
WinIDXX / S&P 10.04% / 5.68% |
WinIDXX / S&P 31.06% / 17.57% |
| 2017-Q23/3 |
WinIDXX / S&P 4.40% / 3.09% |
WinIDXX / S&P 10.18% / 4.83% |
WinIDXX / S&P 31.67% / 17.74% |
| 2017-Q13/3 |
WinIDXX / S&P 31.84% / 6.07% |
WinIDXX / S&P 11.17% / 3.67% |
WinIDXX / S&P 30.43% / 13.32% |
| 2016-Q43/3 |
WinIDXX / S&P 4.03% / 3.82% |
WinIDXX / S&P 10.83% / 2.09% |
WinIDXX / S&P 19.02% / 7.05% |
| 2016-Q33/3 |
WinIDXX / S&P 21.40% / 3.85% |
WinIDXX / S&P 11.45% / 0.20% |
WinIDXX / S&P 27.03% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | IDXX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -14.26% | 20.78% |
| Annualized return | -14.26% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | IDXX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -18.04% | 83.14% |
| Annualized return | -3.90% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | IDXX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 390.27% | 319.30% |
| Annualized return | 17.23% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |